The Research Progress of Herceptin in Treatment of HER-2 Overexpressing Breast Cancer / 昆明医科大学学报
Journal of Kunming Medical University
;
(12): 145-148, 2013.
Article
in Chinese
| WPRIM
| ID: wpr-440901
ABSTRACT
Oncogene activation and inactivation of tumor suppressor genes is an important molecular mechanism of tumor formation. HER-2 oncogene is associated with breast cancer invasion and metastasis and prognosis, HER-2 overexpressing breast cancer progresses rapidly and has poor prognosis. In recent years, the emergence of targeted therapeutic monoclonal antibody drug Herceptin which built its structure for the HER-2 has significantly inproved HER-2-positive advanced breast cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Kunming Medical University
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS